[go: up one dir, main page]

AU2001281067A1 - Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists - Google Patents

Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists

Info

Publication number
AU2001281067A1
AU2001281067A1 AU2001281067A AU8106701A AU2001281067A1 AU 2001281067 A1 AU2001281067 A1 AU 2001281067A1 AU 2001281067 A AU2001281067 A AU 2001281067A AU 8106701 A AU8106701 A AU 8106701A AU 2001281067 A1 AU2001281067 A1 AU 2001281067A1
Authority
AU
Australia
Prior art keywords
pyrrolidine derivatives
gnrh antagonists
novel bicyclic
tricyclic
tricyclic pyrrolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281067A
Inventor
Tania Chernov-Rogan
Mark A. Gallop
Daniel Michael Green
Jeffrey Claude Pelletier
Ge Peng
Stephen Yanovsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001281067A1 publication Critical patent/AU2001281067A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/24—Vacuum evaporation
    • C23C14/28—Vacuum evaporation by wave energy or particle radiation
    • C23C14/30—Vacuum evaporation by wave energy or particle radiation by electron bombardment
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/52—Means for observation of the coating process
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J37/00—Discharge tubes with provision for introducing objects or material to be exposed to the discharge, e.g. for the purpose of examination or processing thereof
    • H01J37/30—Electron-beam or ion-beam tubes for localised treatment of objects
    • H01J37/305—Electron-beam or ion-beam tubes for localised treatment of objects for casting, melting, evaporating, or etching
    • H01J37/3053—Electron-beam or ion-beam tubes for localised treatment of objects for casting, melting, evaporating, or etching for evaporating or etching
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J2237/00—Discharge tubes exposing object to beam, e.g. for analysis treatment, etching, imaging
    • H01J2237/30—Electron or ion beam tubes for processing objects
    • H01J2237/31—Processing objects on a macro-scale
    • H01J2237/3132—Evaporating

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Metallurgy (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plasma & Fusion (AREA)
  • Analytical Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2001281067A 2000-08-04 2001-08-03 Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists Abandoned AU2001281067A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63302500A 2000-08-04 2000-08-04
US09633025 2000-08-04
US09/860,810 US20020065309A1 (en) 1999-08-04 2001-05-18 Novel Bicyclic and tricyclic pyrrolidine derivatives as GnRH antagonists
US09860810 2001-05-18
PCT/US2001/024506 WO2002011732A1 (en) 2000-08-04 2001-08-03 Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists

Publications (1)

Publication Number Publication Date
AU2001281067A1 true AU2001281067A1 (en) 2002-02-18

Family

ID=27091787

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001281067A Abandoned AU2001281067A1 (en) 2000-08-04 2001-08-03 Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists

Country Status (3)

Country Link
US (1) US20020065309A1 (en)
AU (1) AU2001281067A1 (en)
WO (1) WO2002011732A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001025260A1 (en) * 1999-10-07 2001-04-12 Ajinomoto Co., Inc. Process for the production of aspartyldipeptide ester derivatives, novel intermediates therefor and process for the production of the intermediates
US20040176472A1 (en) * 1999-10-07 2004-09-09 Ajinomoto Co., Inc. Process for production of aspartyl dipeptide ester derivative, novel production intermediate therefor, and process for production thereof
WO2005007165A1 (en) 2003-07-07 2005-01-27 Neurocrine Biosciences, Inc. Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
DE602004020638D1 (en) 2003-07-07 2009-05-28 Neurocrine Biosciences Inc PYRIMIDIN-2,4-DION DERIVATIVES AS GONADOTROPINE RELEASING HORMONE RECEPTOR ANTAGONISTS
ATE557007T1 (en) 2003-07-07 2012-05-15 Neurocrine Biosciences Inc ARYLPYRIMIDINE SUITABLE FOR TREATING SEXUAL HORMONE RELATED CONDITIONS SUCH AS ENDOMETRIOSIS, PROSTATE CANCER AND THE LIKE
DE102004033902A1 (en) 2004-07-14 2006-02-16 Zentaris Gmbh New tetrahydrocarbazole compounds are neurokinin-1 receptor antagonists useful to treat or prevent e.g. pubertas praecox, hirsutism, polycystic ovary syndrome, hormone dependent neoplastic diseases and Alzheimer's disease
EP2095818A1 (en) 2008-02-29 2009-09-02 AEterna Zentaris GmbH Use of LHRH antagonists at non-castrating doses
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
WO2012175514A1 (en) 2011-06-21 2012-12-27 Bayer Intellectual Property Gmbh Pyridinone derivatives and pharmaceutical compositions thereof
CN104884457B (en) 2013-10-30 2016-12-07 上海恒瑞医药有限公司 Pyrazolopyrimidinone or pyrrolotriazinone derivatives, preparation method and application in medicine
EP3185881B1 (en) 2014-08-26 2022-03-09 Betanien Hospital Methods, agents and compositions for treatment of inflammatory conditions
CA3073247A1 (en) * 2017-08-18 2019-02-21 Abbvie Inc. Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome and adenomyosis
TW201912157A (en) * 2017-08-18 2019-04-01 美商艾伯維有限公司 Solid pharmaceutical formulation for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome and adenomyosis
MX2020001877A (en) 2017-08-18 2020-09-14 Abbvie Inc Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis.
CN112261942A (en) 2018-04-19 2021-01-22 艾伯维公司 Method for treating severe menstrual bleeding

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756507A (en) * 1995-12-14 1998-05-26 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone

Also Published As

Publication number Publication date
WO2002011732A8 (en) 2002-06-20
WO2002011732A1 (en) 2002-02-14
US20020065309A1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
IL161384A0 (en) Bicyclic oxopyridine and oxopyrimidine derivatives
AU2001263272A1 (en) Tricyclic pyrazole derivatives
AU2002227919A1 (en) Novel sulfonamide-substituted pyrazolopyridine derivatives
AU2001274009A1 (en) Substituted indoles as parp inhibitors
IL158512A0 (en) Novel pyrrole derivatives as pharmaceutical agents
NZ314679A (en) Bicyclic or tricyclic piperidine or pyrrolidine metalloprotease inhibitors, preparation and pharmaceutical compositions thereof
IL148997A0 (en) Bicyclic imidazo-3-yl-amine derivatives
AU2882801A (en) Azepine derivatives
AU2002221827A1 (en) Novel lactame-substituted pyrazolopyridine derivatives
AU2002235224A1 (en) Muscarinic antagonists
PL355206A1 (en) Bicyclic imidazo-3-yl-amine derivatives
AU4203500A (en) Pyrazolopyrimidines as crf antagonists
AU2002320430A1 (en) Novel bicyclic and tricyclic cannabinoids
AU2002346048A1 (en) Benzodiazepine bradykinin antagonists
AU2001281067A1 (en) Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists
IL149010A0 (en) Bicyclic imidazo-5-yl-amine derivatives
AU2001247882A1 (en) Tricyclic protein kinase inhibitors
AU7947000A (en) Tricyclic fused-imidazole derivatives
AU2001236471A1 (en) Imidazopyridines and related azacyclic derivatives as selective modulators of bradykinin b2 receptors
GB0016453D0 (en) Pyrrole derivatives
AU2002211621A1 (en) Tricyclic compounds and uses thereof
AU2001246893A1 (en) Tricyclic quinazolinediones
AU2001275794A1 (en) Pyrrole derivatives
AU2001295455A1 (en) Indoline derivatives as 5ht2c antagonists